Network-1 Technologies, Inc.: Network-1 Reports Second Quarter 2026 Results
Network-1 Technologies (NYSE American:NTIP) reported no revenue for Q2 2026 and $150,000 revenue for the first half of 2025. Operating expenses rose to $1.013M in Q2 and $2.428M in H1 2026. Net loss was $655,000 ($0.03/share) in Q2. Liquidity was $33.75M cash and marketable securities. It also updated patent litigation timelines and declared a $0.05/share dividend.
How this was made
The 30-second read
Why it matters
Q2 shows continued lack of revenue generation, with losses driven by litigation costs. The most tradable elements are liquidity coverage, dividend/repurchase continuity, and the reaffirmed litigation schedule and Federal Circuit remand.
Market read
This is a quarterly update for a litigation-driven IP monetizer, with no revenue but reiterated case catalysts and confirmed liquidity to fund operations.
What to watch
Dividend policy is explicitly subject to board review, and the key catalysts are trial dates (Dec 7, 2026 and Jun 7, 2027) rather than quarterly P&L noise.
Background
Network-1 is an IP monetization company pursuing multiple patent litigations across M2M/IoT, HFT, and Cox portfolios.
Ticker impact
Network-1 reported Q2 2026 results with no revenue, higher litigation-related expenses, and a $1.052M ILiAD remeasurement gain in the first half.
Limited immediate repricing expected unless investors focus on liquidity, dividend sustainability, or litigation progress toward the scheduled 2026 and 2027 trial dates.
The release is a quarterly update with no revenue and modest net-loss changes, but it reiterates material litigation milestones and confirms liquidity and dividend/repurchase activity.
Market effects
Highlights ongoing monetization risk for IP licensing litigators, where revenue visibility depends on case outcomes and licensing settlements.
No clear regional spillover beyond US patent litigation venues (E.D. Texas, S.D.N.Y., Federal Circuit).
Samsung and Google/YouTube-related disputes underscore cross-border tech IP enforcement, but no direct global macro linkage is provided.
Counterpoint
Investors may treat the ILiAD accounting gain and strong cash/working capital as evidence of balance-sheet resilience despite zero revenue.
Key entities
- public_companyNetwork-1 Technologies, Inc.
Subject of the earnings release; reports Q2 2026 results, liquidity, dividend and repurchase activity, and litigation milestones.
- counterpartySamsung Electronics Co., LTD
Defendant in Network-1’s M2M/IoT patent litigation; trial scheduled for June 7, 2027.
- counterpartyGoogle
Named in Cox patent litigation involving Content ID implementations; Federal Circuit remand with trial scheduled for December 7, 2026.
- investment_targetILiAD Biotechnologies, Inc.
Network-1’s investment remeasured after ILiAD’s February 2026 $115M financing, producing a first-half accounting gain.
